Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-06

FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for Olanzapine by Macleods Pharmaceuticals Limited, supporting a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)